乳腺病灶真空辅助切除的患者体验与医疗成本:瑞典VAE随机临床试验报告
瑞典VAE前瞻性单盲随机试验纳入208例乳腺良性病灶行真空辅助切除的患者,178例回答问卷,7G与10G针组在疼痛、并发症和接受度上无显著差异,97%患者愿意推荐该操作,VAE总操作成本较开放手术切除低60%(P<0.001)。
要点
- 7G与10G针组疼痛(P=0.713)、并发症(P=0.724)及接受度(P=0.401)无显著差异。
- 55%(98/178)患者疼痛视觉模拟评分<2分,12%(21/178)>6分。
- 97%(173/178)患者愿意向他人推荐VAE操作。
核心结论
- 7G针VAE被患者良好接受,与10G针相比并发症(包括疼痛)无增加;VAE成本效益优于开放手术切除。
研究设计与样本
- 瑞典VAE前瞻性单盲随机试验,208例患者随机分为7G或10G针组,在超声或乳腺X线引导下行VAE,术后7天和15天记录接受度与短期并发症,6个月和24个月长期随访,并与开放手术切除比较总操作成本。
诊断标准与关键数值
- 疼痛视觉模拟评分范围1–10分,55%(98/178)患者评分<2分,12%(21/178)评分>6分。
- 97%(173/178)患者愿意向他人推荐该操作。
- VAE总医院操作成本较开放手术切除低60%(P<0.001)。
临床应用与阅片要点
- 原文结论认为7G针VAE被患者良好接受且不增加并发症,VAE成本效益优于开放手术切除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Vacuum-assisted excision (VAE) of benign breast lesions is increasingly adopted owing to its clinical performance and convenience. However, the potential complications, impact on patient experience, and healthcare costs need to be thoroughly addressed, which is the focus of this study.
MATERIALS AND METHODS: The Swedish VAE trial was a prospective, single-blind, randomised trial. The patients were randomised to 7G or 10G needle size groups, and VAE was performed under ultrasound or mammographic guidance. Patient acceptance of the method and short-term complications were documented 7 and 15 days after the procedure. Long-term follow-up examinations were performed at 6 and 24 months after the procedure. The total procedural costs were calculated and compared with those of open surgical excision (OSE), the previous standard of care for surgical procedures.
RESULTS: In the trial, VAE was performed on 208 patients, of whom 178 answered a questionnaire regarding their experience. Among those, 87 and 91 had their procedure performed with a 7G and 10G needle, respectively. There were no significant differences in pain levels (p = 0.713), complications (p = 0.724), or patient acceptance of the procedure between the two groups (p = 0.401). Fifty-five per cent (98/178) of all patients reported pain levels < 2 on a visual -analogue scale ranging from 1 to 10, while 12 per cent (21/178) reported pain levels > 6. Ninety-seven per cent (173/178) of the patients would recommend the procedure to others. The total hospital procedural cost of VAE was estimated to be 60 % lower than the cost of OSE (p < 0.001).
CONCLUSION: The VAE procedure using a 7G needle size was well -accepted by patients and conferred no increase in complications, including pain, compared to a 10G needle size. The VAE procedure had superior cost-efficiency compared to OSE.
引用
- Zouzos A, Fredriksson I, Karakatsanis A, et al. Patient experience and healthcare cost aspects of vacuum-assisted excision of breast lesions. A report from the Swedish VAE randomized clinical trial. Eur J Radiol. 2025. PMID: 40127593. doi:10.1016/j.ejrad.2025.112062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。